chloroquine has been researched along with kaf156 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alper, PB; Borboa, R; Brun, R; Caldwell, C; Chang, J; Chatterjee, AK; Chen, Z; Chuan, T; Diagana, TT; Ek, J; Fischli, C; Francek, C; Gagaring, K; Glynne, R; Hollenbeck, T; Isbell, J; Kuhen, K; Lakshminarayana, SB; Li, C; Lin, X; Liu, B; Liu, F; Nagle, A; Plouffe, D; Rottmann, M; Skolnik, S; Tully, DC; Tuntland, T; Wang, J; Winzeler, EA; Wu, T | 1 |
| Hoda, N; Madhav, H | 1 |
1 review(s) available for chloroquine and kaf156
| Article | Year |
|---|---|
An insight into the recent development of the clinical candidates for the treatment of malaria and their target proteins.
Topics: Animals; Antimalarials; Drug Development; Drug Resistance; Humans; Malaria; Molecular Targeted Therapy; Plasmodium; Protozoan Proteins; Small Molecule Libraries | 2021 |
1 other study(ies) available for chloroquine and kaf156
| Article | Year |
|---|---|
Imidazolopiperazines: lead optimization of the second-generation antimalarial agents.
Topics: Animals; Antimalarials; Biological Availability; Caco-2 Cells; Humans; Imidazoles; Malaria, Falciparum; Mice; Mice, Inbred BALB C; Piperazines; Plasmodium falciparum; Rats; Rats, Wistar; Structure-Activity Relationship | 2012 |